ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,748,111, issued on Sept. 29, was assigned to UNIVERSITATSMEDIZIN DER JOHANNES GUTENBERG-UNIVERSITAT MAINZ (Mainz, Germany) and THE SCRIPPS RESEARCH INSTITUTE (La Jolla, Calif.).

"Methods for detection of pathogenic antiphospholipid antibodies and for identification of inhibitors" was invented by Wolfram Ruf (San Diego), Nadine Muller-Calleja (Mainz, Germany), Karl Lackner (Mainz, Germany) and Luc Teyton (La Jolla, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides methods for detecting whether a subject suffers from an autoimmune disease, such as, for example, antiphospholipid syndrome (APS), by detecting antiphospholi...